373 related articles for article (PubMed ID: 25572028)
1. Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study.
Deo R; Katz R; de Boer IH; Sotoodehnia N; Kestenbaum B; Mukamal KJ; Chonchol M; Sarnak MJ; Siscovick D; Shlipak MG; Ix JH
Am J Kidney Dis; 2015 Jul; 66(1):40-6. PubMed ID: 25572028
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).
Ix JH; Katz R; Kestenbaum BR; de Boer IH; Chonchol M; Mukamal KJ; Rifkin D; Siscovick DS; Sarnak MJ; Shlipak MG
J Am Coll Cardiol; 2012 Jul; 60(3):200-7. PubMed ID: 22703926
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-23 and cardiovascular events in CKD.
Scialla JJ; Xie H; Rahman M; Anderson AH; Isakova T; Ojo A; Zhang X; Nessel L; Hamano T; Grunwald JE; Raj DS; Yang W; He J; Lash JP; Go AS; Kusek JW; Feldman H; Wolf M;
J Am Soc Nephrol; 2014 Feb; 25(2):349-60. PubMed ID: 24158986
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C and sudden cardiac death risk in the elderly.
Deo R; Sotoodehnia N; Katz R; Sarnak MJ; Fried LF; Chonchol M; Kestenbaum B; Psaty BM; Siscovick DS; Shlipak MG
Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):159-64. PubMed ID: 20233980
[TBL] [Abstract][Full Text] [Related]
5. Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.
Edmonston D; Wojdyla D; Mehta R; Cai X; Lora C; Cohen D; Townsend RR; He J; Go AS; Kusek J; Weir MR; Isakova T; Pencina M; Wolf M;
Am J Kidney Dis; 2019 Dec; 74(6):771-781. PubMed ID: 31445926
[TBL] [Abstract][Full Text] [Related]
6. Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.
Seiler S; Rogacev KS; Roth HJ; Shafein P; Emrich I; Neuhaus S; Floege J; Fliser D; Heine GH
Clin J Am Soc Nephrol; 2014 Jun; 9(6):1049-58. PubMed ID: 24677555
[TBL] [Abstract][Full Text] [Related]
7. Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Mehta R; Cai X; Lee J; Xie D; Wang X; Scialla J; Anderson AH; Taliercio J; Dobre M; Chen J; Fischer M; Leonard M; Lash J; Hsu CY; de Boer IH; Feldman HI; Wolf M; Isakova T;
Am J Kidney Dis; 2020 Jun; 75(6):908-918. PubMed ID: 31864822
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
Smith K; deFilippi C; Isakova T; Gutiérrez OM; Laliberte K; Seliger S; Kelley W; Duh SH; Hise M; Christenson R; Wolf M; Januzzi J
Am J Kidney Dis; 2013 Jan; 61(1):67-73. PubMed ID: 22883134
[TBL] [Abstract][Full Text] [Related]
9. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline.
Drew DA; Katz R; Kritchevsky S; Ix JH; Shlipak MG; Newman AB; Hoofnagle A; Fried L; Sarnak MJ; Gutierrez OM
Am J Nephrol; 2018; 47(4):242-250. PubMed ID: 29621752
[TBL] [Abstract][Full Text] [Related]
11. Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie).
Drechsler C; Grootendorst DC; Pilz S; Tomaschitz A; Krane V; Dekker F; März W; Ritz E; Wanner C
Am J Kidney Dis; 2011 Oct; 58(4):599-607. PubMed ID: 21820222
[TBL] [Abstract][Full Text] [Related]
12. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
[TBL] [Abstract][Full Text] [Related]
13. Sudden cardiac death in non-dialysis chronic kidney disease patients.
Caravaca F; Chávez E; Alvarado R; García-Pino G; Luna E
Nefrologia; 2016; 36(4):404-9. PubMed ID: 27267917
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
Munoz Mendoza J; Isakova T; Cai X; Bayes LY; Faul C; Scialla JJ; Lash JP; Chen J; He J; Navaneethan S; Negrea L; Rosas SE; Kretzler M; Nessel L; Xie D; Anderson AH; Raj DS; Wolf M;
Kidney Int; 2017 Mar; 91(3):711-719. PubMed ID: 28017325
[TBL] [Abstract][Full Text] [Related]
15. Global Electric Heterogeneity Risk Score for Prediction of Sudden Cardiac Death in the General Population: The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies.
Waks JW; Sitlani CM; Soliman EZ; Kabir M; Ghafoori E; Biggs ML; Henrikson CA; Sotoodehnia N; Biering-Sørensen T; Agarwal SK; Siscovick DS; Post WS; Solomon SD; Buxton AE; Josephson ME; Tereshchenko LG
Circulation; 2016 Jun; 133(23):2222-34. PubMed ID: 27081116
[TBL] [Abstract][Full Text] [Related]
16. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.
Bergmark BA; Udell JA; Morrow DA; Cannon CP; Steen DL; Jarolim P; Budaj A; Hamm C; Guo J; Im K; Kuder JF; Braunwald E; Sabatine MS; O'Donoghue ML
JAMA Cardiol; 2018 Jun; 3(6):473-480. PubMed ID: 29710336
[TBL] [Abstract][Full Text] [Related]
17. Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure.
Wohlfahrt P; Melenovsky V; Kotrc M; Benes J; Jabor A; Franekova J; Lemaire S; Kautzner J; Jarolim P
JACC Heart Fail; 2015 Oct; 3(10):829-39. PubMed ID: 26450001
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D, parathyroid hormone, and sudden cardiac death: results from the Cardiovascular Health Study.
Deo R; Katz R; Shlipak MG; Sotoodehnia N; Psaty BM; Sarnak MJ; Fried LF; Chonchol M; de Boer IH; Enquobahrie D; Siscovick D; Kestenbaum B
Hypertension; 2011 Dec; 58(6):1021-8. PubMed ID: 22068871
[TBL] [Abstract][Full Text] [Related]
19. Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.
Panwar B; Judd SE; Wadley VG; Jenny NS; Howard VJ; Safford MM; Gutiérrez OM
JAMA Cardiol; 2018 Apr; 3(4):318-325. PubMed ID: 29516098
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
Manou E; Thodis E; Arsos G; Pasadakis P; Panagoutsos S; Papadopoulou D; Papagianni A
Kidney Blood Press Res; 2020; 45(6):900-915. PubMed ID: 33040068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
